NCT06433817Recruiting
Spectral CT in Radiotherapy for Cervical Cancer
The Clinical Research of Spectral CT in Radiotherapy for Cervical Cancer
Source: ClinicalTrials.gov · Last updated 30 May 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study was to explore the potential application of spectral CT for radiotherapy in cervical cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 8 May 2024
- Start date
- 22 May 2024
- Primary completion date
- 22 May 2026
- Lead sponsor
- Peking Union Medical College Hospital
- Diseases
- Cervical cancer
- NCT number
- NCT06433817
What you commit to
- Study type: Observational
- Planned participants: 150
- From 22 May 2024 to the primary completion date, 22 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of allergy to intravenous contrast
Other
- CT without spectral scans
- Pregnant or potentially pregnant female subjects
Who the study is looking for
- All patients were confirmed cervical cancer by pathology
- patients were treated with concurrent chemoradiotherapy
- Spectral CT scans acquisition performed during the arterial phase and venous phase
- All the patients underwent a 18F-FDG PET/CT before treatment
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking Union Medical College Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.